Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

Support Statement

This activity is supported by an educational grant from ViiV Healthcare.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

FACULTY

Richard A. Elion, MD
Clinical Professor of Medicine
George Washington University School of Medicine
Co-Director, HIV/HCV Treatment and Research Program
Providence Hospital
Washington, DC

Disclosures:
Consulting Fee: Gilead, ViiV
Speakers Bureau: Gilead, Janssen
Advisor: Gilead, Viiv
Expert Witness: Gilead

Mary Watson Montgomery, M.D.
Associate Physician
Infectious Diseases Division, Brigham & Women's Hospital
Instructor of Medicine
Harvard Medical School
Boston, MA

Disclosures:
No relevant financial relationships to disclose.

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures:
Consulting Fees: AbbVie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline/ViiV, Janssen, Merck
Contracted Research: Bristol-Myers Squibb, Gilead, GlaxoSmithKline/ViiV

Marc O. Siegel, MD
Associate Professor of Medicine
George Washington Medical Faculty Associates
Washington, DC

Disclosures:
No relevant financial relationships to disclose.

Reviewer:

Renslow Sherer, MD
Professor of Medicine
Department of Medicine
The University of Chicago 
Chicago, IL

Disclosures:
Consulting Fees: Gilead

Nurse Planners

Barbara Turk, RN, MPH
Disclosures: No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
Disclosures: No relevant financial relationships to disclose.

Pharmacy Reviewer

Jennifer Cocohoba, PharmD
Disclosure: No relevant financial relationships to disclose.

The University of Chicago Pritzker School of Medicine and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at The University of Chicago Pritzker School of Medicine and Vindico Medical Education, Office of Medical Affairs and Compliance.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education, the American Nurses Credentialing Center, and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, all CME/CNE/CPE providers are required to disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of CME/CNE/CPE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CNE/CPE activity content over which the individual has control. Relationship information appears above.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Accreditation

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education, LLC, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education will provide 1.0 contact hours for nurses.

This program is acceptable for 1.0 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-9999-18-001-H02-P, effective February 15, 2018. This is a knowledge-based activity and there is no fee to participate.

This enduring material is approved for 1 year from the date of original release, February 15, 2018 to February 14, 2019.

How to Participate in this Activity and Obtain CME/CNE/CPE Credit

To participate in this CME/CNE/CPE activity, you must read the objectives, answer the pretest questions, complete one or more scenarios (2 total), answer the CME/CNE/CPE posttest questions, and complete the evaluation. To receive credit, a simulation scenario must be completed with a score of three or more stars (out of five stars). Completion of more scenarios will result in more available credit up the maximum amount for this activity. Upon receipt of the completed materials, The University of Chicago Pritzker School of Medicine will issue an AMA PRA Category 1 Credit(s)™ Certificate, Vindico Medical Education will issue a Learner-paced Contact Hours Certificate, or Vindico Medical Education will issue a Certificate of Pharmacy Credit.

Overview

Highly effective antiretroviral therapy (ART) has transformed HIV from a rapidly deteriorating condition to a complex, chronic condition, with individuals now expecting to live a normal lifespan. With longer survival, patients will be exposed to antiretroviral agents for decades. Therefore, maximizing the safety and tolerability of therapies, as well as preventing resistance, is a high priority. Significant progress has been made toward simplified, single-tablet regimens, optimizing the long-term safety and tolerability of therapy. Despite these advances, clinicians face challenges when selecting and maintaining therapy. In this interactive activity, HIV Patient Management Simulator II, expert faculty will use a case-based approach to discuss various aspects of HIV management, including optimal starting regimens for treatment-naïve patients, as well as the role of switching therapy in treatment-experienced patients. They also will integrate updated guideline recommendations and evidence from recent clinical trials to identify best practices in the management of HIV.

Target Audience

The intended audience for this activity is infectious disease physicians, family physicians, primary care physicians, internal medicine physicians, nurses, pharmacists, and other health care professionals involved in the treatment of patients with HIV.

Purpose/Learning Objectives

Upon successful completion of this educational activity, physicians should be better able to:

• Differentiate HIV antiretroviral agents based on clinical safety and efficacy, barrier to resistance, and recommendations for use.
• Review the impact of proper adherence on minimizing the emergence of resistance and optimizing patient outcomes.
• Identify patients with HIV who may benefit from switching ART.
• Implement treatment strategies for newly diagnosed patients with HIV that reflect the latest clinical evidence, patient preference and characteristics, and potential DDIs.
• Evaluate the latest clinical advances regarding simplified HIV treatment regimens in both newly diagnosed and treatment-experienced patients.
• Review the potential benefits of simplified HIV regimens on patient satisfaction and clinical outcomes.

Upon successful completion of this educational activity, nurses should be better able to:

• Differentiate HIV antiretroviral agents based on clinical safety and efficacy, barrier to resistance, and recommendations for use.
• Review the impact of proper adherence on minimizing the emergence of resistance and optimizing patient outcomes.
• Identify patients with HIV who may benefit from switching ART.
• Evaluate the latest clinical advances regarding simplified HIV treatment regimens in both newly diagnosed and treatment-experienced patients.
• Review the potential benefits of simplified HIV regimens on patient satisfaction and clinical outcomes.

Upon successful completion of this educational activity, pharmacists should be better able to:

• Differentiate HIV antiretroviral agents based on clinical safety and efficacy, barrier to resistance, and recommendations for use.
• Review the impact of proper adherence on minimizing the emergence of resistance and optimizing patient outcomes.
• Identify patients with HIV who may benefit from switching ART.
• Recommend treatment strategies for newly diagnosed patients with HIV that reflect the latest clinical evidence, patient preference and characteristics, and potential DDIs.
• Evaluate the latest clinical advances regarding simplified HIV treatment regimens in both newly diagnosed and treatment-experienced patients.
• Review the potential benefits of simplified HIV regimens on patient satisfaction and clinical outcomes.

Copyright Statement

This CME/CNE/CPE activity is licensed to Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright © 2017 Syandus Inc. and Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from Vindico Medical Education and Syandus Inc.

The material presented at or in any of The University of Chicago Pritzker School of Medicine and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of The University of Chicago Pritzker School of Medicine and Vindico Medical Education. Neither The University of Chicago Pritzker School of Medicine, Vindico Medical Education, the ACCME, the ANCC, the ACPE, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME/CNE/CPE Questions?

Contact us at CME@VindicoCME.com

View Activity

Please note you will be taken to a secondary website for the content & posttest.